FinancialsSector SheetSearch by SectorFilterXFor help & enquiries: 1-888-99-ADVFN (toll free)
Valirx
   

Valirx Company Financial Information

 Company name: Valirx
 EPIC: VAL Trading Currency: GBX
 Market Sector: AIMT ISIN: GB00B23N9136
 Market Segment: AIMI Share Type: DE
 WWW Address:  Description: ORD 1P
 Industry Sector: PHARMACEUTICALS & BIOTECHNOLOGY
 Price Price Change [%] Bid Ask Open High Low Volume
 1.75 mages.advfn.com/imagesnew/2/us/dot 0.0 [0.00] 1.25 2.25 - - - -
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 2.68 153.15 -8.49 4.13 - 0.42 - 5.00 - -

Valirx Key Figures

(at previous day's close)
Market Cap.2.68m
Shares In Issue153.15m
Prev. Close1.75
PE Ratio0.42 
Dividend Yield-%
EPS - basic4.13p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-0.52p
Return On Equity (ROE)-135.23%
Operating Margin-6.14%
PEG Factor- 
EPS Growth Rate-%
Dividends PS Growth Rate-%
Net Debt0.39m
Gross Gearing22.96%
Quick Assets0.11m
Net Working Capital-0.30m
Intangibles / Fixed Assets85.02%
Turnover PS20.08p
Pre-Tax Profit PS-1.23p
Retained Profit PS-1.21p
Cash PS0.01p
Net Cash PS-0.26p
Net Tangible Asset Value PS *-0.03p
Net Asset Value PS0.90p
Spread1.00 (44.44%) 

Valirx Balance Sheet

LSE:VAL:Liabilities+EQLSE:VAL:Assets

Valirx Share Price

Sample Period HighLow
1 week1.75-
4 weeks1.88-
12 weeks2.50-
1 year5.00-

Valirx Share Price (5 years)

Valirx Historic Returns

Giorni da oggi OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week1.75--1.750.05-1.75
4 weeks1.75--1.760.04-1.78
12 weeks1.88-0.13-6.671.900.14-2.01
26 weeks2.00-0.25-12.501.820.12-2.02
1 year3.75-2.00-53.332.330.29-1.95
3 years21.00-19.25-91.679.775.60-25.13
5 years43.50-41.75-95.9810.676.54-26.53

Valirx Key Management Ratios

Valirx Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio0.42 
Tobin's Q Ratio 1.51 
Tobin's Q Ratio (excl. intangibles)3.54 
Dividend Yield-%
Market-to-Book Ratio1.95 
Price-to-Pre-Tax Profit PS-1.42 
Price-to-Retained Profit PS-1.44 
Price-to-Cash Flow PS-3.38 
Price-to-Sales PS0.09 
Price-to-Net Tangible Asset Value PS-54.92 
Price-to-Cash PS170.46 
Net Working Capital PS-0.20 
Price Pct to Working Capital PS-8.96%
Earnings Yield236.00%
Average PE1.15 
Years in average1 
PE to PE average36.84%

Valirx Financial Ratios

(Leverage Ratios)
Debt Ratio-%
Debt-to-Equity Ratio- 
Debt-to-Equity Ratio (excl. Intgbl)- 
Debt-to-Equity Market Value- 
Net Gearing22.08%
Net Gearing (excl. Intangibles)109.18%
Gross Gearing22.96%
Gross Gearing (excl. Intangibles)113.55%
Gearing Under 1 Year22.96%
Gearing Under 1 Year (excl. Intgbl)113.55%
Assets/Equity1.30 
Cash/Equity1.15 
(Liquidity Ratios)
Net Working Capital to Total Assets-16.79%
Current Ratio0.27 
Quick Ratio (Acid Test)0.27 
Liquidity Ratio0.04 
Cash & Equiv/Current Assets14.31%
(Solvency Ratios)
Enterprise Value2.66m
CFO/Sales-0.03 
CFO/Attributable Profit- 
CFO/Assets-0.44 
CFO/Debt-1.94 
Total Debt/Equity Market Value0.15 
Total Debt/Sales0.01 
Total Debt/Pre-Tax Profit-0.22 
Total Debt0.41m
Total Debt/Net Current Assets-1.37%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs1 
Beta (60-Mnth)Beta (36-Mnth)
-8.4935-8.5197
Alpha (60-Mnth)Alpha (36-Mnth)
0.67160.7037

Valirx Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-137.55%
Return On Assets (ROA)-104.61%
Net Profit Margin-6.04%
Assets Turnover17.33 
Return On Equity (ROE)-135.23%
Return On Investment (ROI)-121.98%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-121.26%
Net Income Of Revenues-6.04%
(Asset Utilisation Multiples)
Shareholders Equity Turnover20.09 
Fixed Assets Turnover19.24 
Current Assets Turnover174.97 
Net Working Capital Turnover- 
Inventory Turnover- 
(Other Operating Ratios)
Total Assets-to-Sales0.06 
Debtors-to-Sales0.40%
Debt Collection Period1.47Days

Valirx Dividends

Announcement DateTypeCurr.Dividend AmountPeriod StartPeriod EndEx DateRecord DatePayment DateTotal Dividend Amount
-FinalGBP-12/31/200512/31/2006----
-FinalGBP-12/31/200412/31/2005----
-FinalGBP-12/31/200312/31/2004----
-FinalGBP-12/31/200212/31/2003----
-FinalGBP-12/31/200012/31/2001----
-FinalGBP-12/31/199912/31/2000----
-FinalGBP-12/31/199812/31/1999----

Valirx Fundamentals

 31 Dec 2006 (GBP)31 Dec 2007 (GBP)13 Aug 2008 (GBP)31 Dec 2008 (GBP)
turnover0.01100.00%42.29100.00%42.29100.00%30.75100.00%m
pre tax profit-0.32-3,300.29%-1.29-3.05%-1.29-3.05%-1.89-6.14%m
attributable profit-0.32-3,300.29%-1.29-3.05%-1.29-3.05%-1.86-6.04%m
retained profit-0.32-3,300.29%-1.29-3.05%-1.29-3.05%-1.86-6.04%m
eps - basic-3.30 -4.11 -4.11 4.13 
eps - diluted-3.30 -4.11 -4.11 -4.13 
dividends per share- - - - 

Valirx Balance Sheet

 31 Dec 2006 (GBP)31 Dec 2007 (GBP)13 Aug 2008 (GBP)31 Dec 2008 (GBP)
LSE:VAL:Liabilities+EQLSE:VAL:AssetsLSE:VAL:Liabilities+EQLSE:VAL:AssetsLSE:VAL:Liabilities+EQLSE:VAL:AssetsLSE:VAL:Liabilities+EQLSE:VAL:Assets
 31 Dec 2006 (GBP)31 Dec 2007 (GBP)13 Aug 2008 (GBP)31 Dec 2008 (GBP)
ASSETS
fixed assets fixed assets0.000.17%0.010.50%0.010.50%0.010.54%m
intangibles intangibles0.4917.48%0.6134.61%0.6134.61%1.4279.78%m
fixed investments fixed investments1.3347.78%0.9051.22%0.9051.22%0.2413.51%m
current assets - other current assets - other--%--%--%--%m
stocks stocks--%--%--%--%m
debtors debtors0.155.53%0.158.68%0.158.68%0.095.29%m
cash & securities cash & securities0.8129.04%0.095.00%0.095.00%0.020.88%m
TOTAL2.79100%1.77100%1.77100%1.78100%m
LIABILITIES
creditors - short creditors - short0.113.78%0.105.45%0.105.45%0.4122.96%m
creditors - long creditors - long--%0.000.07%0.000.07%--%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
TOTAL0.113.78%0.105.53%0.105.53%0.4122.96%m
EQUITY
ord cap, reserves ord cap, reserves2.6695.11%1.6995.57%1.6995.57%1.3777.04%m
prefs, minorities prefs, minorities0.031.11%-0.02-1.10%-0.02-1.10%--%m
TOTAL2.6996.22%1.6794.47%1.6794.47%1.3777.04%m
OTHER
NAV Basic- - - - 
NAV Diluted- - - - 

Valirx Cash Flow Statement

31 Dec 2006 (GBP)31 Dec 2007 (GBP)13 Aug 2008 (GBP)31 Dec 2008 (GBP)
Operating CF-0.05-0.84-0.84-0.79m
Pre-Financing CF1.04-0.96-0.96-0.91m
Retained CF0.78-0.72-0.72-0.09m

Valirx Brokers

NameActivityTypeMnemonicCode
Evolution Securities LimitedMarket Maker(MMF)Broker/DealerEVOEVBGGB21MMT
Shore Capital Stockbrokers LdMarket Maker(MMF)Broker/DealerSCAPSHOCGB21
Winterflood Secs LdMarket Maker(MMF)Broker/DealerWINSWNTSGB2LBIC



LSE and PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright1999-2009 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs
ADDITIONAL SERVICES AVAILABLE FROM ADVFN
Upgrade - Click here for more information on ADVFN premium services Money Words - ADVFN Financial Glossary Investor Training ADVFN Financial Bookshop Online Training Academy
30 site:2us lse val091125 02:44 Stock Message Boards ( 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 )